Niklas Armbrust

Niklas Armbrust

Auto-generated profile, based on publicly available information

Niklas Armbrust

Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Nature Methods
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
JGJulian Geilenkeuser
Julian Geilenkeuser
SWStephanie Victoria Wendel
Stephanie Victoria Wendel
JWJulius Clemens Heinrich Wilming
Julius Clemens Heinrich Wilming
NANiklas Armbrust
Niklas Armbrust
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Prime editing (PE) is a powerful gene-editing technique based on targeted gRNA-templated reverse transcription and integration of the de novo synthesized single-stranded DNA. To circumvent one of the main bottlenecks of the method, the competition of the reverse-transcribed 3′ flap with the original 5′ flap DNA, we generated an enhanced fluorescence-activated cell sorting reporter cell line to develop an exonuclease-enhanced PE strategy (‘Exo-PE’) composed of an improved PE complex and an aptamer-recruited DNA-exonuclease to remove the 5′ original DNA flap. Exo-PE achieved better overall editing efficacy than the reference PE2 strategy for insertions ≥30 base pairs in several endogenous loci and cell lines while maintaining the high editing precision of PE2. By enabling the precise incorporation of larger insertions, Exo-PE complements the growing palette of different PE tools and spurs additional refinements of the PE machinery.

7 November 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
NANiklas Armbrust
Niklas Armbrust
JGJulian Geilenkeuser
Julian Geilenkeuser
ELEva-Maria Lederer
Eva-Maria Lederer
TSTobias Heinrich Santl
Tobias Heinrich Santl
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Despite their fundamental role in assessing (patho)physiological cell states, conventional gene reporters can follow gene expression but leave scars on the proteins or substantially alter the mature messenger RNA. Multi-time-point measurements of non-coding RNAs are currently impossible without modifying their nucleotide sequence, which can alter their native function, half-life and localization. Thus, we developed the intron-encoded scarless programmable extranuclear cistronic transcript (INSPECT) as a minimally invasive transcriptional reporter embedded within an intron of a gene of interest. Post-transcriptional excision of INSPECT results in the mature endogenous RNA without sequence alterations and an additional engineered transcript that leaves the nucleus by hijacking the nuclear export machinery for subsequent translation into a reporter or effector protein. We showcase its use in monitoring interleukin-2 (IL2) after T cell activation and tracking the transcriptional dynamics of the long non-coding RNA (lncRNA) NEAT1 during CRISPR interference-mediated perturbation. INSPECT is a method for monitoring gene transcription without altering the mature lncRNA or messenger RNA of the target of interest.

25 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
NANiklas Armbrust
Niklas Armbrust
MGMartin Grosshauser
Martin Grosshauser
JGJulian Geilenkeuser
Julian Geilenkeuser
LSLuisa Stroppel
Luisa Stroppel
MJMattea Jozinovic
Mattea Jozinovic
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Transcriptomics enables comprehensive, multiplexed characterization of cellular states, yet prevailing methods typically require cell fixation or lysis, precluding longitudinal analysis of RNA expression in living cells. Here, we present non-destructive transcriptomics by vesicular export (NTVE), a platform for multi-time-point monitoring of RNA expression dynamics in living cells. Stabilized RNA reporter barcodes can be selectively packaged and exported from cells via virus-like particles (VLPs) bearing bioorthogonal affinity handles for convenient multichannel tracking of co-cultured cells. Using an engineered poly(A)-binding protein adapter, NTVE exports endogenous transcripts from inducible human and murine cell lines with high concordance to conventional lysate-derived RNA-seq. NTVE captures transcriptome changes in response to genetic and chemical perturbations within the same cells over time using standard sequencing workflows. NTVE can further be equipped with fusogens to deliver mRNA-encoded effectors or ribonucleoprotein gene editors from sender cells, activating gene reporters in co-cultured recipient cells. We demonstrate the utility of NTVE for monitoring hiPSC differentiation through daily non-destructive transcriptomic profiling of lineage-specific marker dynamics.

17 November 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RHRafał Hołubowicz
Rafał Hołubowicz
FGFangyuan Gao
Fangyuan Gao
SDSamuel W. Du
Samuel W. Du
CMCarolline Rodrigues Menezes
Carolline Rodrigues Menezes
JZJianye Zhang
Jianye Zhang
KPKrzysztof Palczewski
Krzysztof Palczewski
Emerging molecular therapies introduce enzymatic activity into cells by delivering genes, transcripts, or proteins. Owing to their robust cell-entry capacity, virus-like particles (VLPs) represent a technology of choice in genome editing, where low doses of heterologous proteins and nucleic acids are essential. However, clinical translation of VLP vectors is hindered by inadequate purification methods. Current approaches, relying primarily on ultracentrifugation, suffer from inconsistent product quality and poor scalability. Here, we report the development of a broadly applicable purification strategy that improves the purity and therapeutic efficacy of genome-editing VLPs. Considering the characteristic properties of murine leukemia virus (MLV)-derived engineered VLPs (eVLPs) and HIV-derived engineered nucleocytosolic vehicles for loading of programmable editors (ENVLPEs+), we developed a workflow that involves single- and multi-modal chromatographic steps, effectively removing host cell proteins and cell-culture contaminants while improving VLP integrity and biological activity. Our purified VLPs displayed superior protein composition, consistency, and enhanced functional delivery compared to VLPs partially purified by conventional ultracentrifugation methods. Mass spectrometric analysis revealed a substantial decrease in contaminants, with VLP-specific proteins comprising >90% of the final product. In vivo studies confirmed improved therapeutic outcomes when chromatographically purified VLPs were used. Our scalable purification platform addresses critical manufacturing bottlenecks and constitutes a starting point for further development of VLP therapeutics, enabling robust production of pure VLPs for diverse applications such as genome editing, vaccine development, and other uses that require intracellular protein delivery.

12 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NANiklas Armbrust
Niklas Armbrust
MGMartin Grosshauser
Martin Grosshauser
JGJulian Geilenkeuser
Julian Geilenkeuser
LSLuisa Stroppel
Luisa Stroppel
MJMattea Jozinovic
Mattea Jozinovic
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Transcriptomics enables comprehensive, multiplexed characterization of cellular states, yet prevailing methods typically require cell fixation or lysis, precluding longitudinal analysis of RNA expression in living cells. Here, we present non-destructive transcriptomics by vesicular export (NTVE), a platform for multi-time-point monitoring of RNA expression dynamics in living cells. Stabilized RNA reporter barcodes can be selectively packaged and exported from cells via virus-like particles (VLPs) bearing bioorthogonal affinity handles for convenient multichannel tracking of co-cultured cells. Using an engineered poly(A)-binding protein adapter, NTVE exports endogenous transcripts from inducible human and murine cell lines with high concordance to conventional lysate-derived RNA-seq. NTVE captures transcriptome changes in response to genetic and chemical perturbations within the same cells over time using standard sequencing workflows. NTVE can further be equipped with fusogens to deliver mRNA-encoded effectors or ribonucleoprotein gene editors from sender cells, activating gene reporters in co-cultured recipient cells. We demonstrate the utility of NTVE for monitoring hiPSC differentiation through daily non-destructive transcriptomic profiling of lineage-specific marker dynamics.

2 September 2026 in Nature
Verified
Journal Article
Open access
PDF file
MSMaren Kirstin Schuhmacher
Maren Kirstin Schuhmacher
CGChristoph Gruber
Christoph Gruber
CLChristopher M. R. Lang
Christopher M. R. Lang
RRRicardo M. W. Ruijpers
Ricardo M. W. Ruijpers
LMLyupka Mazneykova
Lyupka Mazneykova
WWWolfgang Wurst
Wolfgang Wurst
Evolution guides biological systems to populate ecological niches, with viruses among the most successful examples of this principle. Viruses evolved over billions of years to efficiently transfer genetic information. Although viruses are highly diverse, most have converged towards remarkable similarity in the size and shape of their capsids 1,2 . By contrast, generative models for protein design enable the creation of protein architectures that are absent from nature 3–5 . Here we investigate whether protein assemblies designed by artificial intelligence can be functionalized to construct nucleic acid transport vehicles that are independent of evolutionary trajectories. By combining natural protein domains with synthetic protein assemblies, we create more than 100 bottom-up RNA transfer vehicles with unique sizes and shapes. These vehicles surpass the RNA transfer efficiency of widely used delivery vehicles by several orders of magnitude. In addition, we demonstrate that their tropism can be programmed by incorporation of computationally designed peptide binders and use them to deliver therapeutically relevant cargo RNAs into a wide range of cellular models. We show the in vivo biodistribution of one of these vehicles in a mouse at near-single-cell resolution, confirm its safety, and use it to perform a gene-editing treatment strategy for Duchenne muscular dystrophy in patient-derived cells and a pig. Our work demonstrates how proteins created by generative artificial intelligence can be harnessed for the rational engineering of RNA transport systems with the desired properties by overcoming the limitations of natural protein diversity.